| SC 13G/A | 2024-01-02 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 198,300 | 6.5% | EDGAR |
| SC 13G/A | 2023-11-17 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 231,115 | 7.6% | EDGAR |
| SC 13G/A | 2023-11-06 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 195,780 | 6.4% | EDGAR |
| SC 13G/A | 2023-08-07 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 4,100,000 | 10.7% | EDGAR |
| SC 13G/A | 2023-07-17 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 3,700,000 | 11.1% | EDGAR |
| SC 13G/A | 2023-07-07 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 3,305,000 | 9.9% | EDGAR |
| SC 13G | 2023-06-30 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 2,830,000 | 8.5% | EDGAR |
| SC 13G/A | 2023-06-22 | Ruck Matthew J | Sonnet BioTherapeutics Holdings, Inc. | 1,700,000 | 6.2% | EDGAR |
| SC 13G/A | 2023-06-14 | Ruck Matthew J | Sonnet BioTherapeutics Holdings, Inc. | 1,603,006 | 5.8% | EDGAR |
| SC 13G/A | 2023-06-14 | Ruck Matthew J | Sonnet BioTherapeutics Holdings, Inc. | 1,603,006 | 5.8% | EDGAR |
| SC 13G | 2023-06-12 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 2,720,000 | 9.9% | EDGAR |
| SC 13G | 2023-06-09 | Ruck Matthew J | Sonnet BioTherapeutics Holdings, Inc. | 1,547,426 | 5.6% | EDGAR |
| SC 13G/A | 2023-05-26 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 2,300,000 | 8.4% | EDGAR |
| SC 13G/A | 2023-05-17 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 1,880,839 | 6.8% | EDGAR |
| SC 13G | 2023-05-02 | Markey John | Sonnet BioTherapeutics Holdings, Inc. | 1,320,507 | 6.5% | EDGAR |
| SC 13G/A | 2023-02-10 | Hudson Bay Capital Management LP | Sonnet BioTherapeutics Holdings, Inc. | 242,856 | 3.0% | EDGAR |
| SC 13G | 2022-02-03 | Hudson Bay Capital Management LP | Sonnet BioTherapeutics Holdings, Inc. | 3,400,000 | 5.3% | EDGAR |
| SC 13G | 2021-03-10 | Mohan Pankaj | Sonnet BioTherapeutics Holdings, Inc. | 942,959 | 5.5% | EDGAR |
| SC 13G/A | 2021-02-16 | Arena Investors LP | Sonnet BioTherapeutics Holdings, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | Altium Capital Management LP | Sonnet BioTherapeutics Holdings, Inc. | 5,664,728 | 5.0% | EDGAR |